bioAffinity Technologies, Inc.
BIAF- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001712762
No open-market purchases or sales by bioAffinity Technologies, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $782.5K in total; no superinvestor holds it.
Other share classesBIAFW
Holders of 5% or more of BIAF
Holders whose latest Schedule 13D or 13G filing reports 5% or more of bioAffinity Technologies, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Crumly Richard K. | 13G | 11.20%3.21M shares | New | May 14, 20251 filing | May 14, 2025 | SEC |
| Bigger Capital Fund L P | 13G | 5.79%117.4K shares | New | Oct 1, 20251 filing | Oct 1, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on bioAffinity Technologies, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 1, 20257:03 PM ET | Bigger Capital Fund L Pand 6 others | 13G | 5.79%117.4K shares | New | Sep 29, 2025 | SEC |
| May 14, 20255:26 PM ET | Crumly Richard K.and 2 others | 13G | 11.20%3.21M shares | New | May 7, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell bioAffinity Technologies, Inc. shares.
No Form 144 notices for bioAffinity Technologies, Inc. are on file.